Document is current

Any future updates will be listed below

Correction to: SLC39A1 contribute to malignant progression and have clinical prognostic impact in gliomas

Crossref DOI link: https://doi.org/10.1186/s12935-024-03556-2

Published Online: 2024-11-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark